Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/29195
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-10-24T12:04:30Z | - |
dc.date.available | 2022-10-24T12:04:30Z | - |
dc.date.issued | 2006-12-19 | - |
dc.identifier.citation | Köseler, A. vd. (2007). "Frequency of mutated allele CYP2D6*4 in the Turkish population". Pharmacology, 79(4), 203-206. | en_US |
dc.identifier.issn | 0031-7012 | - |
dc.identifier.uri | https://doi.org/10.1159/000100959 | - |
dc.identifier.uri | https://www.karger.com/Article/Abstract/100959 | - |
dc.identifier.uri | http://hdl.handle.net/11452/29195 | - |
dc.description.abstract | The frequency of functionally important mutations and alleles of the gene coding for CYP2D6 shows wide ethnic variations. The present study aimed to determine the most common mutated allele CYP2D6*4 gene in a Turkish population of 100 unrelated subjects, by using real-time PCR with fluorescent probe. CYP2D6*4 allele was not detected in 62 subjects ( 62%). Among the remaining 38 subjects (38%), 4 (4%) were carriers of two *4 alleles, being homozygous for CYP2D6 and genotyped as CYP2D6*4/*4.34 subjects (34%) were carriers of one *4 allele, being heterozygous for CYP2D6*4. The frequency of allele *4 was 0.21. These data indicate that 4% of the Turkish individuals living in the city of Bursa are carriers of two nonfunctional mutated alleles *4, being homozygous for CYP2D6*4. It is clinically important to be able to identify those individuals who are likely to have altered pharmacokinetics for CYP2D6 substrates in order to avoid adverse drug reactions. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | CYP2D6 | en_US |
dc.subject | Polymorphism | en_US |
dc.subject | Real-time PCR | en_US |
dc.subject | Hydroxylation polymorphisms | en_US |
dc.subject | Cytochrome-P450 enzymes | en_US |
dc.subject | Genetic polymorphisms | en_US |
dc.subject | Russian population | en_US |
dc.subject | Swedish population | en_US |
dc.subject | Cyp2c19 genotypes | en_US |
dc.subject | Cyp2d6 genes | en_US |
dc.subject | Debrisoquine | en_US |
dc.subject | Chinese | en_US |
dc.subject | 2d6 | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.mesh | Cytochrome P-450 CYP2D6 | en_US |
dc.subject.mesh | Gene frequency | en_US |
dc.subject.mesh | Genetics, population | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Polymorphism, genetic | en_US |
dc.subject.mesh | Reverse transcriptase polymerase Chain Reaction | en_US |
dc.title | Frequency of mutated allele CYP2D6*4 in the Turkish population | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000247028600002 | tr_TR |
dc.identifier.scopus | 2-s2.0-34249820794 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-4832-0436 | tr_TR |
dc.identifier.startpage | 203 | tr_TR |
dc.identifier.endpage | 206 | tr_TR |
dc.identifier.volume | 79 | tr_TR |
dc.identifier.issue | 4 | tr_TR |
dc.relation.journal | Pharmacology | en_US |
dc.contributor.buuauthor | Köseler, Aylin | - |
dc.contributor.buuauthor | İlçöl, Yasemin Özarda | - |
dc.contributor.buuauthor | Ulus, İsmail. H. | - |
dc.contributor.researcherid | D-5340-2015 | tr_TR |
dc.contributor.researcherid | AAE-8710-2020 | tr_TR |
dc.contributor.researcherid | AAL-8873-2021 | tr_TR |
dc.identifier.pubmed | 17374963 | tr_TR |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 9844734800 | tr_TR |
dc.contributor.scopusid | 35741320500 | tr_TR |
dc.contributor.scopusid | 7004271086 | tr_TR |
dc.subject.scopus | Cytochrome P-450 CYP2D6; Pharmacogenomics; Racemorphan | en_US |
dc.subject.emtree | Homozygote | en_US |
dc.subject.emtree | Cytochrome P450 2D6 | en_US |
dc.subject.emtree | Fluorescent dye | en_US |
dc.subject.emtree | Allele | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Fluorescence | en_US |
dc.subject.emtree | Gene frequency | en_US |
dc.subject.emtree | Gene identification | en_US |
dc.subject.emtree | Gene mutation | en_US |
dc.subject.emtree | Genotype | en_US |
dc.subject.emtree | Heterozygote | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Reverse transcription polymerase chain reaction | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Normal human | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.